Therefore, the identification of natural compounds that can inhibit both AChE and BChE represents a promising therapeutic strategy for AD, as it may help restore cholinergic function and mitigate the neurodegenerative processes associated with this condition [92,93]. The gene discussed is BCHE; the disease is Alzheimer disease.